Different histamine actions in proximal and distal human coronary arteries in vitro. 1990

M Keitoku, and Y Maruyama, and T Takishima
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

OBJECTIVE The aim was to investigate the receptor mechanisms for different histamine actions in proximal and distal human coronary arteries. METHODS Postmortem human coronary rings precontracted by 50 mM KCl were exposed to histamine (10(-8)-10(-4) M) in control and after treatment with 10(-5) M pyrilamine (an H1 receptor antagonist), or 10(-4) M cimetidine (an H2 receptor antagonist), and/or endothelial removal. Tension changes at the point of maximum relaxation (at 10(-5) M in most rings) were obtained. RESULTS Endothelium dependent relaxations to histamine were clearly distinguished from endothelium independent relaxations by their transient nature and their inhibition by pyrilamine, but not by cimetidine. While most distal rings (group I, n = 42/58) and only some of the proximal rings (group II, n = 10/83) showed greater than 50% relaxation with histamine, nearly half the proximal rings (group III, n = 40/83) showed only contraction. Significant differences were found between group I and III, but not II, in control [-66(SD 15.2)% v +25(20.4)%, p less than 0.001] and after pyrilamine treatment [-66(9.2)% v -25(12.0)%, p less than 0.001], cimetidine treatment [-30(25.5)% v +42(20.9)%, p less than 0.001] and endothelial removal [-24(37.1)% v +36(20.2)%, p less than 0.01]. However, a combination of cimetidine and endothelial removal resulted in a contraction to histamine which was similar among the three groups. CONCLUSIONS These results suggest that hypercontractility to histamine was found in proximal human coronary arteries, but not in distal ones, probably due to the reduction of both direct and endothelial mediated relaxations rather than to an increase in the contraction itself.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009126 Muscle Relaxation That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Relaxations,Relaxation, Muscle,Relaxations, Muscle
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011738 Pyrilamine A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies. Mepyramine,Pyranisamine,Anthisan,Boots Bite & Sting Relief,Kriptin,Mepyramine Maleate,Pyrilamine Maleate,Maleate, Mepyramine,Maleate, Pyrilamine
D011968 Receptors, Histamine Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action. Histamine Binding Sites,Histamine Receptors,Histamine Receptor,Binding Sites, Histamine,Receptor, Histamine,Sites, Histamine Binding
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary

Related Publications

M Keitoku, and Y Maruyama, and T Takishima
August 1987, Circulation research,
M Keitoku, and Y Maruyama, and T Takishima
January 1988, Proceedings of the Western Pharmacology Society,
M Keitoku, and Y Maruyama, and T Takishima
October 2009, European journal of pharmacology,
M Keitoku, and Y Maruyama, and T Takishima
August 1983, British journal of pharmacology,
M Keitoku, and Y Maruyama, and T Takishima
July 1990, Naunyn-Schmiedeberg's archives of pharmacology,
M Keitoku, and Y Maruyama, and T Takishima
October 1994, Journal of cardiovascular pharmacology,
M Keitoku, and Y Maruyama, and T Takishima
March 1997, Journal of molecular and cellular cardiology,
M Keitoku, and Y Maruyama, and T Takishima
May 1986, The American journal of physiology,
M Keitoku, and Y Maruyama, and T Takishima
June 1978, The Journal of thoracic and cardiovascular surgery,
Copied contents to your clipboard!